Literature DB >> 21833789

Role of osteopontin in early phase of renal crystal formation: immunohistochemical and microstructural comparisons with osteopontin knock-out mice.

Masahito Hirose1, Keiichi Tozawa, Atsushi Okada, Shuzo Hamamoto, Yuji Higashibata, Bin Gao, Yutaro Hayashi, Hideo Shimizu, Yasue Kubota, Takahiro Yasui, Kenjiro Kohri.   

Abstract

Osteopontin (OPN) is an important matrix protein of renal calcium stone. However, the function of OPN in the early phase of renal crystal formation is not well defined. In this study, we examined OPN expression in the early phase of renal crystal formation with ultra-microstructural observations and immuno-TEM (transmission electron microscopy) in control and OPN knock-out (OPN-KO) mice. Glyoxylate (100 mg/kg) was intra-abdominally administered to male wild-type mice (C57BL/6, 8 weeks of age) and OPN-KO mice (C57BL/6, 8 weeks of age). Kidney was collected before and 6, 12, and 24 h after administration. We examined the relation between renal crystal formation and microstructural OPN location using TEM and immunohistochemical staining of OPN as well as western blotting and quantitative RT-PCR for OPN. OPN protein expression gradually increased in the renal cortex-medulla junction after glyoxylate administration, and OPN mRNA was increased until 12 h, but decreased at 24 h. In ultra-microstructural observation, OPN began to appear on the luminal side of renal distal tubular cells at 6 h and was gradually detected in the tubular lumen at 12 h. OPN was present in the crystal nuclei and collapsed mitochondria in the tubular lumen. In the OPN-KO mice, collapsed mitochondria were present, but no crystal nuclei formation were detected at 24 h. Based on the results this study proposed that the appearance of organelles, such as mitochondria and microvilli, in the tubular lumen after cell injury may be the starting point of crystal nucleus formation due to the aggregation ability of OPN.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21833789     DOI: 10.1007/s00240-011-0400-z

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  42 in total

1.  Impact of various modifiers on calcium oxalate crystallization.

Authors:  Sevsen Kulaksizoglu; Mustafa Sofikerim; Cemal Cevik
Journal:  Int J Urol       Date:  2007-03       Impact factor: 3.369

2.  Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin.

Authors:  T Wada; M D McKee; S Steitz; C M Giachelli
Journal:  Circ Res       Date:  1999-02-05       Impact factor: 17.367

Review 3.  Osteopontin in urinary stone formation.

Authors:  J R Hoyer; L Otvos; L Urge
Journal:  Ann N Y Acad Sci       Date:  1995-04-21       Impact factor: 5.691

4.  [Structural characteristics of osteopontin for calcium oxalate crystal].

Authors:  T Umekawa
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  1999-03

5.  Contribution of human uropontin to inhibition of calcium oxalate crystallization.

Authors:  J R Asplin; D Arsenault; J H Parks; F L Coe; J R Hoyer
Journal:  Kidney Int       Date:  1998-01       Impact factor: 10.612

Review 6.  Osteopontin and calcium stone formation.

Authors:  Jack G Kleinman; Jeffrey A Wesson; Jeremy Hughes
Journal:  Nephron Physiol       Date:  2004

7.  Effects of impaired functional domains of osteopontin on renal crystal formation: Analyses of OPN transgenic and OPN knockout mice.

Authors:  Shuzo Hamamoto; Shintaro Nomura; Takahiro Yasui; Atsushi Okada; Masahiro Hirose; Hideo Shimizu; Yasunori Itoh; Keiichi Tozawa; Kenjiro Kohri
Journal:  J Bone Miner Res       Date:  2009-12-14       Impact factor: 6.741

8.  Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta.

Authors:  T Ikeda; T Shirasawa; Y Esaki; S Yoshiki; K Hirokawa
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

9.  Second prize: Comprehensive proteomic analysis of human calcium oxalate monohydrate kidney stone matrix.

Authors:  Benjamin K Canales; Lorraine Anderson; Leeann Higgins; Joel Slaton; Ken P Roberts; Nathan Liu; Manoj Monga
Journal:  J Endourol       Date:  2008-06       Impact factor: 2.942

10.  Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques.

Authors:  E R O'Brien; M R Garvin; D K Stewart; T Hinohara; J B Simpson; S M Schwartz; C M Giachelli
Journal:  Arterioscler Thromb       Date:  1994-10
View more
  17 in total

1.  Recurrent urolithiasis following parathyroidectomy for primary hyperparathyroidism.

Authors:  C Rowlands; A Zyada; S Zouwail; H Joshi; M J Stechman; D M Scott-Coombes
Journal:  Ann R Coll Surg Engl       Date:  2013-10       Impact factor: 1.891

2.  Osteopontin protects against high phosphate-induced nephrocalcinosis and vascular calcification.

Authors:  Neil J Paloian; Elizabeth M Leaf; Cecilia M Giachelli
Journal:  Kidney Int       Date:  2016-03-09       Impact factor: 10.612

3.  In situ flow cell platform for examining calcium oxalate and calcium phosphate crystallization on films of basement membrane extract in the presence of urinary 'inhibitors'.

Authors:  Cary A Kuliasha; Douglas Rodriguez; Archana Lovett; Laurie B Gower
Journal:  CrystEngComm       Date:  2020-02-05       Impact factor: 3.545

4.  AGEs induce ectopic endochondral ossification in intervertebral discs

Authors:  S Illien-Jünger; O M Torre; W F Kindschuh; X Chen; D M Laudier; J C Iatridis
Journal:  Eur Cell Mater       Date:  2016-11-18       Impact factor: 3.942

5.  Biomimetic Randall's plaque as an in vitro model system for studying the role of acidic biopolymers in idiopathic stone formation.

Authors:  Archana Chidambaram; Douglas Rodriguez; Saeed Khan; Laurie Gower
Journal:  Urolithiasis       Date:  2014-08-15       Impact factor: 3.436

6.  Hydroxycitrate prevents calcium oxalate crystallization and kidney injury in a nephrolithiasis rat model.

Authors:  Bowei Yang; Jiongming Li; Bin Wang; Guang Wang; Pei Li; Haixiang Guo; Yuhang Li; Tongxin Yang
Journal:  Urolithiasis       Date:  2021-08-19       Impact factor: 3.436

Review 7.  Biomolecular mechanism of urinary stone formation involving osteopontin.

Authors:  Kenjiro Kohri; Takahiro Yasui; Atsushi Okada; Masahito Hirose; Shuzo Hamamoto; Yasuhiro Fujii; Kazuhiro Niimi; Kazumi Taguchi
Journal:  Urol Res       Date:  2012-11-06

8.  Genome-Wide Gene Expression Profiling of Randall's Plaques in Calcium Oxalate Stone Formers.

Authors:  Kazumi Taguchi; Shuzo Hamamoto; Atsushi Okada; Rei Unno; Hideyuki Kamisawa; Taku Naiki; Ryosuke Ando; Kentaro Mizuno; Noriyasu Kawai; Keiichi Tozawa; Kenjiro Kohri; Takahiro Yasui
Journal:  J Am Soc Nephrol       Date:  2016-06-13       Impact factor: 10.121

9.  Multifunctional role of osteopontin in directing intrafibrillar mineralization of collagen and activation of osteoclasts.

Authors:  Douglas E Rodriguez; Taili Thula-Mata; Edgardo J Toro; Ya-Wen Yeh; Carl Holt; L Shannon Holliday; Laurie B Gower
Journal:  Acta Biomater       Date:  2013-10-17       Impact factor: 8.947

Review 10.  Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.

Authors:  Florian Kahles; Hannes M Findeisen; Dennis Bruemmer
Journal:  Mol Metab       Date:  2014-03-22       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.